Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients

Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study

(2014) Kristjan Paulson et al.   BRITISH JOURNAL OF HAEMATOLOGY

Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death

(2013) Jessica K. Altman et al.   LEUKEMIA RESEARCH

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

(2011) J. H. Park et al.   BLOOD

Treatment advances have not improved the early death rate in acute promyelocytic leukemia

(2011) J. S. McClellan et al.   HAEMATOLOGICA

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry

(2011) S Lehmann et al.   LEUKEMIA

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

(2010) M. A. Sanz et al.   BLOOD

Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience

(2009) Charikleia Kelaidi et al.   JOURNAL OF CLINICAL ONCOLOGY

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

(2008) P. Montesinos et al.   BLOOD